Prelude Capital Management, LLC Theravance Biopharma, Inc. Call Options Transaction History
Prelude Capital Management, LLC
- $1.39 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TBPH
# of Institutions
131Shares Held
44.2MCall Options Held
13.9KPut Options Held
3.1K-
Madison Avenue Partners, LP New York, NY8.51MShares$75.8 Million12.2% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$66.4 Million3.74% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$33.7 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$24.6 Million2.86% of portfolio
-
Newtyn Management, LLC New York, NY2.12MShares$18.9 Million3.93% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $595M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...